Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial

• Autori principali: Julia Karady (Autore), Robert W McGarrah (Autore), Maggie Nguyen (Autore), Stephanie N Giamberardino (Autore), Nandini Meyersohn (Autore), Michael T Lu (Autore), Pedro V Staziaki (Autore), Stefan B Puchner (Autore), Daniel O Bittner (Autore), Borek Foldyna (Autore), Thomas Mayrhofer (Autore), Margery A Connelly (Autore), Andre Tchernof (Autore), Phillip J White (Autore), Khurram Nasir (Autore), Kathleen Corey (Autore), Deepak Voora (Autore), Neha Pagidipati (Autore), Geoffrey S Ginsburg (Autore), William E Kraus (Autore), Udo Hoffmann (Autore), Pamela S Douglas (Autore), Svati H Shah (Autore), Maros Ferencik (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2024-06-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Objectives: To determine the relationship between lipoprotein particle size/number with hepatic steatosis (HS), given its association with traditional lipoproteins and coronary atherosclerosis. Methods: Individuals with available CT data and blood samples enrolled in the PROMISE trial were studied....